Indexed keywords
AZATHIOPRINE;
CHLORPHENIRAMINE MALEATE;
CORTICOSTEROID;
DEFLAZACORT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
PARACETAMOL;
PREDNISONE;
RITUXIMAB;
ADULT;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
CYSTITIS;
FEMALE;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
HYPERGLYCEMIA;
HYPOTENSION;
IMMUNOFLUORESCENCE MICROSCOPY;
OSTEOPENIA;
PEMPHIGUS VULGARIS;
SIDE EFFECT;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD19;
ANTIGENS, CD20;
B-LYMPHOCYTE SUBSETS;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
PEMPHIGUS;
PREDNISONE;
REMISSION INDUCTION;
2
0028209673
Correlation of subclasses of IgG with disease activity in pemphigus vulgaris
Bhol K, Mohimen A, Ahmed AR. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology 1994 : 189 (Suppl. 1 85 89.
(1994)
Dermatology , vol.189
, Issue.SUPPL. 1
, pp. 85-89
Bhol, K.1
Mohimen, A.2
Ahmed, A.R.3
3
0036800757
Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies
Hacker MK, Janson M, Fairley JA, et al. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Clin Immunol 2002 : 105 : 264 274.
(2002)
Clin Immunol , vol.105
, pp. 264-274
Hacker, M.K.1
Janson, M.2
Fairley, J.A.3
4
0033938305
Humoral and cellular autoimmunity in autoimmune bullous skin disorders
Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 2000 : 122 : 91 100.
(2000)
Int Arch Allergy Immunol , vol.122
, pp. 91-100
Hertl, M.1
5
0031028992
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris
Lin MS, Swartz SJ, Lopez A, et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 1997 : 99 : 31 40.
(1997)
J Clin Invest , vol.99
, pp. 31-40
Lin, M.S.1
Swartz, S.J.2
Lopez, A.3
6
0031213740
Regulation of B-cell commitment to plasma cells or to memory B cells
Liu YJ, Banchereau J. Regulation of B-cell commitment to plasma cells or to memory B cells. Semin Immunol 1997 : 9 : 235 240.
(1997)
Semin Immunol , vol.9
, pp. 235-240
Liu, Y.J.1
Banchereau, J.2
7
0033911628
Patterns of remission in pemphigus vulgaris
Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000 : 42 : 422 427.
(2000)
J Am Acad Dermatol , vol.42
, pp. 422-427
Herbst, A.1
Bystryn, J.C.2
8
2942537697
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004 : 350 : 2572 2581.
(2004)
N Engl J Med , vol.350
, pp. 2572-2581
Edwards, J.C.1
Szczepanski, L.2
Szechinski, J.3
9
0033958155
New and emerging therapies in the treatment of blistering diseases
Korman NJ. New and emerging therapies in the treatment of blistering diseases. Dermatol Clin 2000 : 18 : 127 137.
(2000)
Dermatol Clin , vol.18
, pp. 127-137
Korman, N.J.1
10
0642312825
Rituximab (monoclonal anti-CD20 antibody): Mechanisms of action and resistance
Smith MR. Rituximab (monoclonal anti-CD20 antibody): Mechanisms of action and resistance. Oncogene 2003 : 22 : 7359 7368.
(2003)
Oncogene , vol.22
, pp. 7359-7368
Smith, M.R.1
11
0037819344
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
Boye J, Elter T, Engert A. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 2003 : 14 : 520 535.
(2003)
Ann Oncol , vol.14
, pp. 520-535
Boye, J.1
Elter, T.2
Engert, A.3
12
0034468110
The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders
Treon SP, Anderson KC. The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders. Semin Oncol 2000 : 27 : 79 85.
(2000)
Semin Oncol , vol.27
, pp. 79-85
Treon, S.P.1
Anderson, K.C.2
13
0028057250
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994 : 83 : 435 445.
(1994)
Blood , vol.83
, pp. 435-445
Reff, M.E.1
Carner, K.2
Chambers, K.S.3
14
0032033127
Humoral immunity due to long-lived plasma cells
Slifka MK, Antia R, Whitmire JK, et al. Humoral immunity due to long-lived plasma cells. Immunity 1998 : 8 : 363 372.
(1998)
Immunity , vol.8
, pp. 363-372
Slifka, M.K.1
Antia, R.2
Whitmire, J.K.3
